From Access to Adherence: The Challenges of Antiretroviral Treatment - Studies from Botswana, Tanzania and Uganda, 2006: 1. On hunger, transport costs and waiting time: a synthesis of challenges to ARV adherence in three African countries: References

From Access to Adherence: The Challenges of Antiretroviral Treatment - Studies from Botswana, Tanzania and Uganda, 2006
(2006; 320 pages)

Table of Contents

Acknowledgments
Acronyms and abbreviations
Foreword
1. On hunger, transport costs and waiting time: a synthesis of challenges to ARV adherence in three African countries
	Introduction
	Methods
	Discussion
	Conclusion
	References
2. Overview of antiretroviral therapy, adherence and drug-resistance
	Background
	References
3. From training to action: the process of engaging health professionals in operational research on adherence to antiretroviral therapy
	Introduction
	Promoting the rational use of drugs
	Promoting Rational Drug Use in the Community course
	Three ARV adherence studies: the process
	How the process was funded
	Discussion and conclusion
	References
	Annex 1: PRDUC course participants by region, type of institution, sex and source of funding
	Annex 2: URLs for country proposals
	Annex 3: Call for proposals
4. There's hope - early observations of ARV treatment roll-out in South Africa
Factors that facilitate or constrain adherence to antiretroviral therapy among adults at four public health facilities in Botswana: a pre-intervention study
	Acknowledgements
	Acronyms and abbreviations
	Executive summary
	Chapter 1: Introduction
		1.1 Research problem
		1.2 Research questions
		1.3 Study objectives
	Chapter 2: Background
		2.1 History of HIV and AIDS in Botswana
		2.2 Botswana's ART programme
		2.3 Literature review
		2.4 Definition of concepts
	Chapter 3: Methodology
		3.1 Introduction
		3.2 Study design
		3.3 Study population
		3.4 Description of study sites
		3.5 Inclusion and exclusion criteria
		3.6 Selection and training of data collectors
		3.7 Qualitative data collection
		3.8 Observations
		3.9 Semi-structured interviews
		3.10 Exit interviews
		3.11 Focus group discussions
		3.12 Quantitative data
		3.13 Data analysis
		3.14 Emic perspective
		3.15 Ethical considerations
		3.16 Feedback
	Chapter 4: Quantitative results
		4.1 Adherence measurement tool results
		4.2 Rates of adherence to ARVs
		4.3 Reasons for skipping medication
		4.4 Factors affecting adherence to ART
		4.5 Predictors of adherence to ART
		4.6 Quantitative results of exit interviews
	Chapter 5: Qualitative results
		5.1 Constraints to adherence to ART
		5.2 Facilitators of adherence to ART
		5.3 Observation of health facilities 5.3.1 Structural issues
		5.4 National level policy issues
	Chapter 6: Discussion, conclusion and recommendations
		6.1 Discussion
		6.2 Conclusions
		6.3 Recommendations
	References
	Annex 1: Mean of rates adherence
	Annex 2: Multivariate logistic regression analyses on the predictor variables
	Annex 3: Questionnaires
A study on antiretroviral adherence in Tanzania: a pre-intervention perspective, 2005
	Acknowledgements
	Acronyms and abbreviations
	Executive summary
	Chapter 1: Introduction
		1.1 Background
		1.2 Rationale
		1.3 Literature review
		1.4 Problem statement
		1.5 Objectives
		1.6 Output
	Chapter 2: Methodology
		2.1 Study design
		2.2 Study population
		2.3 Inclusion and exclusion criteria for interviewees
		2.4 Quantitative data
		2.5 Qualitative data
		2.6 Data collection tools
		2.7 Pilot study
		2.8 Sample size and sampling strategy
		2.9 Data collection
		2.10 Ethics
	Chapter 3: Study areas
		3.1 Health care facilities
	Chapter 4: Quantitative results
		4.1 Demographic characteristics of ARV users
		4.2 Adherence rates
	Chapter 5: Qualitative results
		5.1 Factors that influence adherence to ARVs from the users' perspective
		5.2 Quality of operating structures
		5.3 Opinions and suggestions given by respondents to improve provision of ARVs
	Chapter 6: Discussion, conclusion and recommendations
		6.1 Discussion
		6.2 Conclusion
		6.3 Recommendations
		6.4 Proposed interventions
	References
	Annex 1: Exit interview with ARV users
	Annex 2: Semi-structured interview with ARV users
	Annex 3: ARV users, FGDs
	Annex 4: Adherence measurement tools
	Annex 5: Key informant interview
	Annex 6: Semi-structured interviews (with staff)
	Annex 7: Observation (consultations)
	Annex 8: Observation of antiretroviral
Factors that facilitate or constrain adherence to antiretroviral therapy among adults in Uganda: a pre-intervention study
	Acknowledgements
	Glossary
	Executive summary
	Chapter 1: Introduction
		1.1 Background
		1.2 Research problem
		1.3 Research objective
	Chapter 2: Background to the study
		2.1 History of AIDS in Uganda
		2.2 History of ARVs in Uganda
	Chapter 3: Literature review
		3.1 Importance of adherence to ART
		3.2 Measurement of adherence
		3.3 Factors affecting adherence to ART
		3.4 Impact of the drug regimen on adherence
		3.5 Treatment characteristics affecting adherence 3.5.1 Physical state and disease stage
		3.6 The clinic setting and service provision
		3.7 Simplifying treatment regimes to improve adherence
		3.8 Conceptual framework
	Chapter 4: Methodology
		4.1 Study design
		4.2 Study population
		4.3 Inclusion and exclusion criteria
		4.4 Sample size and selection
		4.5 Data collector selection and training
		4.6 Pilot testing
		4.7 Data collection
		4.8 Data analysis
		4.9 Evaluation of methods
		4.10 Ethical considerations
	Chapter 5: Description of the study sites
		5.1 Jinja Regional Referral Hospital
		5.2 Nile Treatment Centre
		5.3 Study limitations
	Chapter 6: Results
		6.1 Demographic characteristics of ARV users
		6.2 Factors influencing adherence to ART
	Chapter 7: Discussion, conclusions and recommendations
		7.1 Discussion
		7.2 Conclusions
		7.3 Recommendations
	References
Back cover

References

1. Akileswaran C et al. (2005). Lessons learned from use of highly active antiretroviral therapy in Africa. Clinical Infectious Diseases; 41:376-385.

2. American Public Health Association (June 2004). Adherence to HIV treatment regimens: recommendations for best practices. Available at: www.apha.org/ppp/hiv.

3. Bennet S, Boerma JT, Brugha R (2006). Scaling up of HIV/AIDS evaluation. Lancet, 367:79-82.

4. Carrieri MP et al. (2003). Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study. Antiviral Therapy, 8(6):585-94.

5. Chesney MA (2000). Factors affecting adherence to antiretroviral therapy. Clinical Infectious Diseases, 30 (Suppl 2):S171-176.

6. Coetzee D et al. (2004). Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. AIDS, 18(Suppl 3):S27-31.

7. DiMatteo MR (2004). Variations in patients' adherence to medical recommendations. A quantitative review of 50 years of research. Medical Care, 42:200-209.

8. Farmer F et al. (2001). Community-based approaches to HIV treatment in resource-poor settings. Lancet, 358:404-409.

9. G8 Gleneagles Summit. Chair's summary, 8^h July 2005. Available at: http://www.g8.gov.uk/

10. Gill CJ et al. (2005). No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. AIDS, 19:1243-1249.

11. Hardon A, Hodgkin C, Fresle D. How to investigate the use of medicines by consumers. Geneva, World Health Organization, 2004.

12. Ivers LC, Kendrick D, Doucette K (2005). Efficacy of antiretroviral therapy programmes in resource-poor settings: a meta-analysis of the published literature. Clinical Infectious Diseases, 41:217-224.

13. Jaffar S et al. (2005). Antiretroviral treatment in resource-poor settings: public health research priorities. Tropical Medicine and International Health, 2005; 10:295-299.

14. Kent DM et al. (2003). Suitable monitoring approaches to antiretroviral therapy in resource- poor settings: setting the research agenda. Clinical Infectious Diseases, 37 (Suppl l):S13-24.

15. Koenig SP, Léandre F, Farmer PE (2004). Scaling-up HIV treatment programmes in resource-limited settings: the rural Haiti experience. AIDS, 18 (Suppl 3):S21-25.

16. Laurent C et al. (2002). The Senegalese Government's highly active antiretroviral therapy initiative: an 18-month follow-up study. AIDS, 16:1363-1370.

17. Orrell C et al. (2003). Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS, 17:1369-1375.

18. Oyugi JH et al. (2004). Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in resource-limited setting. Journal of Acquired Immune Deficiency Syndrome, 36:1100-1102.

19. Paterson DL et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 2000;122:21-30.

20. Spire B et al. (2002). Adherence to highly active antiretroviral therapy (HAART) in HIV- infected patients: from a predictive to a dynamic approach. Social Science and Medicine, 54(10):1481-96.

21. UNAIDS. 2006 Report on the global AIDS epidemic. Geneva, United Nations Joint Programme on AIDS, 2006.

22. Vitolins MZ et al. (2000). Measuring adherence to behavioral and medical interventions. Controlled Clinical Trials 2000; 21:188S-194S.

23. Weiser S et al. (2003). Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. Journal of Acquired Immune Deficiency Syndromes, 34:281-288.

24. WHO. Adherence to HIV treatment. Geneva, World Health Organization, 2004.

25. WHO/UNAIDS. Progress on global access to HIV antiretroviral therapy: a report on "3 by 5" and beyond. Geneva, World Health Organization/United Nations Joint Programme on AIDS, 2006.